🧫

Enteric Alpha-Synuclein Propagation and ENS Dysfunction in PD Mouse Model

active
experiment Created: 2026-04-26T06:56:03 By: etl-v1-backfill Quality: 50% ✓ SciDEX ID: exp-2c20043e4b80
🧫 Experiment Protocol In-VivoParkinson diseaseMouse (C57BL/6 or Thy1-αSyn transgenic), gut injection modelproposed
Determine whether alpha-synuclein fibrils injected into the gut lumen propagate via the vagus nerve to the brainstem and whether ENS dysfunction constitutes a self-reinforcing feedback loop in a preformed PD mouse model.
PRIMARY OUTCOME
p-Syn (Ser129) pathology burden in vagus nerve and brainstem DMV
EXPECTED OUTCOMES
Alpha-synuclein pathology detected in vagus nerve and dorsal motor nucleus by 6 months post-injection, with progressive ENS dysfunction evidenced by delayed gut transit.
SUCCESS CRITERIA
p-Syn (Ser129) IHC in vagus and DMV; threshold: pathology score > 2 in treatment vs. control groups.
PROTOCOL
in-vivo
Source: auto-generated
🧫 Experiment Extras
ESTIMATED COST
$48,000
TIMELINE
12 months
MARKET PRICE
$0.50
STATUS
proposed
Scoring Dimensions
Info Gain 0.82 (25%) Feasibility 0.78 (20%) Hyp Coverage 0.88 (20%) Cost Effect. 0.75 (15%) Novelty 0.80 (10%) Ethical Safety 0.00 (10%)0.850composite
Metadataorigin_type: v1_polymorphic_backfill
origin_typev1_polymorphic_backfill
source_tableexperiments
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.